Fingerprint
Dive into the research topics of 'Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
Johnny Mahlangu, Radoslaw Kaczmarek, Annette Von Drygalski, Susan Shapiro, Sheng Chieh Chou, Margareth C. Ozelo, Gili Kenet, Flora Peyvandi, Michael Wang, Bella Madan, Nigel S. Key, Michael Laffan, Amy L. Dunn, Jane Mason, Doris V. Quon, Emily Symington, Andrew D. Leavitt, Johannes Oldenburg, Hervé Chambost, Mark T. Reding
Research output: Contribution to journal › Article › peer-review
64
Scopus
citations